Michael Becich

SpIntellx, Inc. operates as a computational pathology company. It applies its proprietary artificial intelligence technologies to analyze whole slide image pathology samples based on spatial analytics. The company was founded by D. Lansing Taylor, S. Chakra Chennubhotla, Jeffrey L. Fine and Michael J. Becich and is headquartered in Pittsburgh, PA.

The Group's is seeking out suitable candidates for a business combination with a private company. The Company previously developed and sold digital tissue imaging and telemedicine applications linking dispersed users and data primarily in the healthcare and pharmaceutical markets. The Group was operating in two segments: Product and Software Support. Its digital imaging products, MedMicroTM, and DSMTM, provide a digital platform to share, store, and analyze tissue images. The Group's telemedicine product provides healthcare organizations with a cost effective platform for remote examination, diagnosis, and treatment of patients. The major customers of the Group was pharmaceutical - Pfizer, GlaxoSmithKline, Sanofi-Aventis, Merck, Abbott Laboratories and Boston Scientific.